MDC/CCL22 intrathecal levels in patients with multiple sclerosis

Daniela Galimberti, C. Fenoglio, C. Comi, D. Scalabrini, M. De Riz, M. Leone, E. Venturelli, F. Cortini, M. Piola, F. Monaco, N. Bresolin, E. Scarpini

Research output: Contribution to journalArticle

Abstract

MDC/CCL22 has been detected in the brain of mice with experimental autoimmune encephalomyelitis. MDC/CCL22 cerebrospinal fluid levels were evaluated in 56 patients with multiple sclerosis (MS) and in 17 controls. No significant differences were found, even when stratifying patients according to the disease subtype. Stratifying by gender, significantly increased MDC/CCL22 levels were observed in female patients when compared with female controls and male patients (109.03 versus 98.54 and 99.37 pg/mL, P = 0.034 and 0.018, respectively). Therefore, MDC/CCL22 is likely to play a role in the development of MS in females only, possibly influencing the intracerebral recruitment of Th2 cells, which produce anti-inflammatory cytokines.

Original languageEnglish
Pages (from-to)547-549
Number of pages3
JournalMultiple Sclerosis Journal
Volume14
Issue number4
DOIs
Publication statusPublished - May 2008

Fingerprint

Multiple Sclerosis
Th2 Cells
Autoimmune Experimental Encephalomyelitis
Cerebrospinal Fluid
Anti-Inflammatory Agents
Cytokines
Brain

Keywords

  • Cerebrospinal fluid
  • MDC/CCL22
  • Multiple sclerosis

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

MDC/CCL22 intrathecal levels in patients with multiple sclerosis. / Galimberti, Daniela; Fenoglio, C.; Comi, C.; Scalabrini, D.; De Riz, M.; Leone, M.; Venturelli, E.; Cortini, F.; Piola, M.; Monaco, F.; Bresolin, N.; Scarpini, E.

In: Multiple Sclerosis Journal, Vol. 14, No. 4, 05.2008, p. 547-549.

Research output: Contribution to journalArticle

Galimberti, Daniela ; Fenoglio, C. ; Comi, C. ; Scalabrini, D. ; De Riz, M. ; Leone, M. ; Venturelli, E. ; Cortini, F. ; Piola, M. ; Monaco, F. ; Bresolin, N. ; Scarpini, E. / MDC/CCL22 intrathecal levels in patients with multiple sclerosis. In: Multiple Sclerosis Journal. 2008 ; Vol. 14, No. 4. pp. 547-549.
@article{a5869e989fe6423f88994cef999270f1,
title = "MDC/CCL22 intrathecal levels in patients with multiple sclerosis",
abstract = "MDC/CCL22 has been detected in the brain of mice with experimental autoimmune encephalomyelitis. MDC/CCL22 cerebrospinal fluid levels were evaluated in 56 patients with multiple sclerosis (MS) and in 17 controls. No significant differences were found, even when stratifying patients according to the disease subtype. Stratifying by gender, significantly increased MDC/CCL22 levels were observed in female patients when compared with female controls and male patients (109.03 versus 98.54 and 99.37 pg/mL, P = 0.034 and 0.018, respectively). Therefore, MDC/CCL22 is likely to play a role in the development of MS in females only, possibly influencing the intracerebral recruitment of Th2 cells, which produce anti-inflammatory cytokines.",
keywords = "Cerebrospinal fluid, MDC/CCL22, Multiple sclerosis",
author = "Daniela Galimberti and C. Fenoglio and C. Comi and D. Scalabrini and {De Riz}, M. and M. Leone and E. Venturelli and F. Cortini and M. Piola and F. Monaco and N. Bresolin and E. Scarpini",
year = "2008",
month = "5",
doi = "10.1177/1352458507084268",
language = "English",
volume = "14",
pages = "547--549",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - MDC/CCL22 intrathecal levels in patients with multiple sclerosis

AU - Galimberti, Daniela

AU - Fenoglio, C.

AU - Comi, C.

AU - Scalabrini, D.

AU - De Riz, M.

AU - Leone, M.

AU - Venturelli, E.

AU - Cortini, F.

AU - Piola, M.

AU - Monaco, F.

AU - Bresolin, N.

AU - Scarpini, E.

PY - 2008/5

Y1 - 2008/5

N2 - MDC/CCL22 has been detected in the brain of mice with experimental autoimmune encephalomyelitis. MDC/CCL22 cerebrospinal fluid levels were evaluated in 56 patients with multiple sclerosis (MS) and in 17 controls. No significant differences were found, even when stratifying patients according to the disease subtype. Stratifying by gender, significantly increased MDC/CCL22 levels were observed in female patients when compared with female controls and male patients (109.03 versus 98.54 and 99.37 pg/mL, P = 0.034 and 0.018, respectively). Therefore, MDC/CCL22 is likely to play a role in the development of MS in females only, possibly influencing the intracerebral recruitment of Th2 cells, which produce anti-inflammatory cytokines.

AB - MDC/CCL22 has been detected in the brain of mice with experimental autoimmune encephalomyelitis. MDC/CCL22 cerebrospinal fluid levels were evaluated in 56 patients with multiple sclerosis (MS) and in 17 controls. No significant differences were found, even when stratifying patients according to the disease subtype. Stratifying by gender, significantly increased MDC/CCL22 levels were observed in female patients when compared with female controls and male patients (109.03 versus 98.54 and 99.37 pg/mL, P = 0.034 and 0.018, respectively). Therefore, MDC/CCL22 is likely to play a role in the development of MS in females only, possibly influencing the intracerebral recruitment of Th2 cells, which produce anti-inflammatory cytokines.

KW - Cerebrospinal fluid

KW - MDC/CCL22

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=46749157569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749157569&partnerID=8YFLogxK

U2 - 10.1177/1352458507084268

DO - 10.1177/1352458507084268

M3 - Article

C2 - 18208895

AN - SCOPUS:46749157569

VL - 14

SP - 547

EP - 549

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 4

ER -